Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ALPINE IMMUNE SCIENCES, INC.ALPN · Entity 90802 | Director | January 02, 2020 | January 07, 2020 |
| Apnimed, Inc.APMD · Entity 4910 | Director | July 30, 2026 | August 03, 2026 |
| Axcella Health Inc.AXLA · Entity 116059 | Director | May 19, 2022 | May 25, 2022 |
| Enumeral Biomedical Holdings, Inc.ENUM · Entity 179878 | Director | December 09, 2016 | December 13, 2016 |
| Longboard Pharmaceuticals, Inc.LBPH · Entity 85536 | Director | December 02, 2024 | December 03, 2024 |
| Tessera Defense & Homeland Security Inc.PHGE · Entity 8384 | Director | July 28, 2021 | July 30, 2021 |
| VEEVA SYSTEMS INCVEEV · Entity 2124 | Director | September 01, 2026 | September 03, 2026 |
| vTv Therapeutics Inc.VTVT · Entity 6614 | Director · Pres, CEO and Exec Chairperson | February 17, 2026 | February 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ALPINE IMMUNE SCIENCES, INC.
Report date January 02, 2020 · Filed January 07, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.62 · Expires 2030-01-01 | Direct | 7,650 |
Reported balance
After 2020-01-02 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-01-02 · Grant · Acquired 7,650 · Balance 7,650 F1: The exercise price is equal to the closing price per share of Common Stock as reported on the Nasdaq Global Market on the date of grant. F2: 1/12th of the shares subject to the option become vested and exercisable on February 2, 2020 and 1/12th of the shares subject to the option shall vest monthly thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: The exercise price is equal to the closing price per share of Common Stock as reported on the Nasdaq Global Market on the date of grant.
F2: 1/12th of the shares subject to the option become vested and exercisable on February 2, 2020 and 1/12th of the shares subject to the option shall vest monthly thereafter.
Apnimed, Inc.
Report date July 30, 2026 · Filed August 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 12,500 |
Reported balance
After 2026-08-03 transaction · row 1
1 source rowRow 1 · 2026-08-03 · Purchase · Acquired 12,500 · Balance 12,500 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.15 · Expires 2036-05-28 | Direct | 0 |
Reported balance
After 2026-08-03 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-08-03 · Disposition to issuer · Disposed 169,468 · Balance 0 F1: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock. F2: One-third of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after June 1, 2026, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 24 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.15 · Expires 2036-05-28 | Direct | 169,468 |
Reported balance
After 2026-08-03 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-08-03 · Grant · Acquired 169,468 · Balance 169,468 F1: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock. F2: One-third of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after June 1, 2026, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 24 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $16.00 · Expires 2036-07-29 | Direct | 155,558 |
Reported balance
After 2026-07-30 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-07-30 · Grant · Acquired 155,558 · Balance 155,558 F2: One-third of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after June 1, 2026, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 24 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $16.00 · Expires 2036-07-29 | Direct | 0 |
Reported balance
After 2026-08-03 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-08-03 · Disposition to issuer · Acquired 155,558 · Balance 0 F1: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock. F2: One-third of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after June 1, 2026, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 24 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $16.00 · Expires 2036-07-29 | Direct | 155,558 |
Reported balance
After 2026-08-03 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-08-03 · Grant · Acquired 155,558 · Balance 155,558 F1: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock. F2: One-third of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after June 1, 2026, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 24 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $16.00 · Expires 2036-07-29 | Direct | 22,238 |
Reported balance
After 2026-07-30 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-07-30 · Grant · Acquired 22,238 · Balance 22,238 F3: The shares subject to such option vest and become exercisable in substantially equal monthly installments for a period of 36 months after July 30, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $16.00 · Expires 2036-07-29 | Direct | 0 |
Reported balance
After 2026-08-03 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-08-03 · Disposition to issuer · Disposed 22,238 · Balance 0 F1: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock. F3: The shares subject to such option vest and become exercisable in substantially equal monthly installments for a period of 36 months after July 30, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $16.00 · Expires 2036-07-29 | Direct | 22,238 |
Reported balance
After 2026-08-03 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2026-08-03 · Grant · Acquired 22,238 · Balance 22,238 F1: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock. F3: The shares subject to such option vest and become exercisable in substantially equal monthly installments for a period of 36 months after July 30, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock.
F2: One-third of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after June 1, 2026, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 24 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.
F3: The shares subject to such option vest and become exercisable in substantially equal monthly installments for a period of 36 months after July 30, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date.
Axcella Health Inc.
Report date May 19, 2022 · Filed May 25, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.70 · Expires 2032-05-18 | Direct | 40,000 |
Reported balance
After 2022-05-19 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-05-19 · Grant · Acquired 40,000 · Balance 40,000 F1: This option shall vest and become exercisable in twelve equal quarterly installments following the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: This option shall vest and become exercisable in twelve equal quarterly installments following the grant date.
Enumeral Biomedical Holdings, Inc.
Report date December 09, 2016 · Filed December 13, 2016
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 175,000 |
Reported balance
After 2016-12-09 transaction · row 1
1 source rowRow 1 · 2016-12-09 · Exercise / conversion · Acquired 175,000 · Balance 175,000 |
| Common Stock Purchase WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $2.00 · Expires 2019-07-30 | Direct | 43,750 |
Reported balance
After 2016-12-09 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2016-12-09 · Purchase · Acquired 43,750 · Balance 43,750 F2: The Reporting Person acquired the reported Warrants in a private sale transaction for cash consideration in the amount of $0.08 per warrant. F1: The Common Stock Purchase Warrants (the "Warrants") are exercisable immediately. |
| Common Stock Purchase WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $0.50 · Expires 2016-12-09 | Direct | 175,000 |
Reported balance
After 2016-12-09 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2016-12-09 · Other · Acquired 175,000 · Balance 175,000 F3: Pursuant to an Offer to Amend and Exercise launched by the Issuer on October 28, 2016 (as subsequently amended, the "Offering"), the exercise price of each Warrant tendered in the Offering was reduced to $0.50 per Warrant, and participants in the Offering received four shares for each Warrant tendered rather than one share. Pursuant to the terms of the Offering, the expiration date of tendered Warrants was accelerated to December 9, 2016. The Reporting Person tendered all of the Warrants beneficially owned in the Offering. F1: The Common Stock Purchase Warrants (the "Warrants") are exercisable immediately. |
| Common Stock Purchase WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $0.50 · Expires 2016-12-09 | Direct | 0 |
Reported balance
After 2016-12-09 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2016-12-09 · Exercise / conversion · Disposed 175,000 · Balance 0 F3: Pursuant to an Offer to Amend and Exercise launched by the Issuer on October 28, 2016 (as subsequently amended, the "Offering"), the exercise price of each Warrant tendered in the Offering was reduced to $0.50 per Warrant, and participants in the Offering received four shares for each Warrant tendered rather than one share. Pursuant to the terms of the Offering, the expiration date of tendered Warrants was accelerated to December 9, 2016. The Reporting Person tendered all of the Warrants beneficially owned in the Offering. F1: The Common Stock Purchase Warrants (the "Warrants") are exercisable immediately. |
Filing footnotes · ownership attribution and instrument terms
F1: The Common Stock Purchase Warrants (the "Warrants") are exercisable immediately.
F2: The Reporting Person acquired the reported Warrants in a private sale transaction for cash consideration in the amount of $0.08 per warrant.
F3: Pursuant to an Offer to Amend and Exercise launched by the Issuer on October 28, 2016 (as subsequently amended, the "Offering"), the exercise price of each Warrant tendered in the Offering was reduced to $0.50 per Warrant, and participants in the Offering received four shares for each Warrant tendered rather than one share. Pursuant to the terms of the Offering, the expiration date of tendered Warrants was accelerated to December 9, 2016. The Reporting Person tendered all of the Warrants beneficially owned in the Offering.
Longboard Pharmaceuticals, Inc.
Report date December 02, 2024 · Filed December 03, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.62 · Expires 2030-12-10 | Direct | 0 |
Reported balance
After 2024-12-02 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-12-02 · Disposition to issuer · Disposed 25,461 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of 10/14/2024, by and among Longboard Pharmaceuticals, Inc. (the "Issuer"), H. Lundbeck A/S ("Parent"), Lundbeck LLC ("Payor"), and Langkawi Corporation ("Purchaser"), on 12/02/2024, Purchaser completed a tender offer for shares of common stock of the Issuer (each, a "Share") and thereafter merged with and into the Issuer, with the Issuer continuing as the surviving corporation and an indirect wholly owned subsidiary of Parent (the "Merger"). F2: On such date and at such time as the certificate of merger in respect of the Merger was duly filed with the Secretary of State of the State of Delaware in accordance with the DGCL (the "Effective Time"), pursuant to the Merger Agreement, each outstanding option, to the extent unvested, was accelerated and became fully vested and exercisable. Each outstanding and unexercised vested option (after giving effect to the acceleration treatment set forth in the preceding sentence) at the Effective Time was cancelled and automatically converted into the right to receive cash, without interest, in an amount equal to the product of (i) the total number of Shares subject to such option as of immediately prior to the Effective Time multiplied by (ii) the excess of (x) $60.00 per Share over (y) the exercise price payable per Share under such option, which amount will be subject to any withholding taxes. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.40 · Expires 2032-05-23 | Direct | 0 |
Reported balance
After 2024-12-02 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-12-02 · Disposition to issuer · Disposed 12,367 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of 10/14/2024, by and among Longboard Pharmaceuticals, Inc. (the "Issuer"), H. Lundbeck A/S ("Parent"), Lundbeck LLC ("Payor"), and Langkawi Corporation ("Purchaser"), on 12/02/2024, Purchaser completed a tender offer for shares of common stock of the Issuer (each, a "Share") and thereafter merged with and into the Issuer, with the Issuer continuing as the surviving corporation and an indirect wholly owned subsidiary of Parent (the "Merger"). F2: On such date and at such time as the certificate of merger in respect of the Merger was duly filed with the Secretary of State of the State of Delaware in accordance with the DGCL (the "Effective Time"), pursuant to the Merger Agreement, each outstanding option, to the extent unvested, was accelerated and became fully vested and exercisable. Each outstanding and unexercised vested option (after giving effect to the acceleration treatment set forth in the preceding sentence) at the Effective Time was cancelled and automatically converted into the right to receive cash, without interest, in an amount equal to the product of (i) the total number of Shares subject to such option as of immediately prior to the Effective Time multiplied by (ii) the excess of (x) $60.00 per Share over (y) the exercise price payable per Share under such option, which amount will be subject to any withholding taxes. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.06 · Expires 2033-05-24 | Direct | 0 |
Reported balance
After 2024-12-02 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-12-02 · Disposition to issuer · Disposed 12,500 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of 10/14/2024, by and among Longboard Pharmaceuticals, Inc. (the "Issuer"), H. Lundbeck A/S ("Parent"), Lundbeck LLC ("Payor"), and Langkawi Corporation ("Purchaser"), on 12/02/2024, Purchaser completed a tender offer for shares of common stock of the Issuer (each, a "Share") and thereafter merged with and into the Issuer, with the Issuer continuing as the surviving corporation and an indirect wholly owned subsidiary of Parent (the "Merger"). F2: On such date and at such time as the certificate of merger in respect of the Merger was duly filed with the Secretary of State of the State of Delaware in accordance with the DGCL (the "Effective Time"), pursuant to the Merger Agreement, each outstanding option, to the extent unvested, was accelerated and became fully vested and exercisable. Each outstanding and unexercised vested option (after giving effect to the acceleration treatment set forth in the preceding sentence) at the Effective Time was cancelled and automatically converted into the right to receive cash, without interest, in an amount equal to the product of (i) the total number of Shares subject to such option as of immediately prior to the Effective Time multiplied by (ii) the excess of (x) $60.00 per Share over (y) the exercise price payable per Share under such option, which amount will be subject to any withholding taxes. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.94 · Expires 2034-05-22 | Direct | 0 |
Reported balance
After 2024-12-02 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2024-12-02 · Disposition to issuer · Disposed 22,500 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of 10/14/2024, by and among Longboard Pharmaceuticals, Inc. (the "Issuer"), H. Lundbeck A/S ("Parent"), Lundbeck LLC ("Payor"), and Langkawi Corporation ("Purchaser"), on 12/02/2024, Purchaser completed a tender offer for shares of common stock of the Issuer (each, a "Share") and thereafter merged with and into the Issuer, with the Issuer continuing as the surviving corporation and an indirect wholly owned subsidiary of Parent (the "Merger"). F2: On such date and at such time as the certificate of merger in respect of the Merger was duly filed with the Secretary of State of the State of Delaware in accordance with the DGCL (the "Effective Time"), pursuant to the Merger Agreement, each outstanding option, to the extent unvested, was accelerated and became fully vested and exercisable. Each outstanding and unexercised vested option (after giving effect to the acceleration treatment set forth in the preceding sentence) at the Effective Time was cancelled and automatically converted into the right to receive cash, without interest, in an amount equal to the product of (i) the total number of Shares subject to such option as of immediately prior to the Effective Time multiplied by (ii) the excess of (x) $60.00 per Share over (y) the exercise price payable per Share under such option, which amount will be subject to any withholding taxes. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of 10/14/2024, by and among Longboard Pharmaceuticals, Inc. (the "Issuer"), H. Lundbeck A/S ("Parent"), Lundbeck LLC ("Payor"), and Langkawi Corporation ("Purchaser"), on 12/02/2024, Purchaser completed a tender offer for shares of common stock of the Issuer (each, a "Share") and thereafter merged with and into the Issuer, with the Issuer continuing as the surviving corporation and an indirect wholly owned subsidiary of Parent (the "Merger").
F2: On such date and at such time as the certificate of merger in respect of the Merger was duly filed with the Secretary of State of the State of Delaware in accordance with the DGCL (the "Effective Time"), pursuant to the Merger Agreement, each outstanding option, to the extent unvested, was accelerated and became fully vested and exercisable. Each outstanding and unexercised vested option (after giving effect to the acceleration treatment set forth in the preceding sentence) at the Effective Time was cancelled and automatically converted into the right to receive cash, without interest, in an amount equal to the product of (i) the total number of Shares subject to such option as of immediately prior to the Effective Time multiplied by (ii) the excess of (x) $60.00 per Share over (y) the exercise price payable per Share under such option, which amount will be subject to any withholding taxes.
Tessera Defense & Homeland Security Inc.
Report date July 28, 2021 · Filed July 30, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 12,500 |
Reported balance
After 2021-07-28 transaction · row 1
1 source rowRow 1 · 2021-07-28 · Purchase · Acquired 12,500 · Balance 12,500 F1: The common stock and common stock warrant were acquired in the issuer's registered direct offering of units, in which each unit consisted of one share of common stock and one common stock warrant to purchase 0.75 of a share of common stock, at a price of $4.00 per unit. The price paid per unit is reflected in Table I. |
| Common Stock WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $5.00 · Expires 2027-01-28 | Direct | 9,375 |
Reported balance
After 2021-07-28 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-07-28 · Purchase · Acquired 9,375 · Balance 9,375 F1: The common stock and common stock warrant were acquired in the issuer's registered direct offering of units, in which each unit consisted of one share of common stock and one common stock warrant to purchase 0.75 of a share of common stock, at a price of $4.00 per unit. The price paid per unit is reflected in Table I. F2: The common stock warrant will be exercisable six months after the date of issuance, at an exercise price of $5.00 per share and will expire five years from the date such warrant first becomes exercisable. |
Filing footnotes · ownership attribution and instrument terms
F1: The common stock and common stock warrant were acquired in the issuer's registered direct offering of units, in which each unit consisted of one share of common stock and one common stock warrant to purchase 0.75 of a share of common stock, at a price of $4.00 per unit. The price paid per unit is reflected in Table I.
F2: The common stock warrant will be exercisable six months after the date of issuance, at an exercise price of $5.00 per share and will expire five years from the date such warrant first becomes exercisable.
VEEVA SYSTEMS INC
Report date September 01, 2026 · Filed September 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 15,651 |
Reported balance
After 2026-09-01 transaction · row 1
1 source rowRow 1 · 2026-09-01 · Exercise / conversion · Acquired 460 · Balance 15,651 F1: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 1,381 |
Reported balance
After 2026-09-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-01 · Exercise / conversion · Disposed 460 · Balance 1,381 F2: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer. F1: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act. F3: On June 17, 2026, the Reporting Person was granted 1,841 RSUs under the Issuer's Amended & Restated 2013 Equity Incentive Plan, of which 1/4 of the RSUs vested on September 1, 2026, with the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service on the Issuer's board of directors on the applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act.
F2: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer.
F3: On June 17, 2026, the Reporting Person was granted 1,841 RSUs under the Issuer's Amended & Restated 2013 Equity Incentive Plan, of which 1/4 of the RSUs vested on September 1, 2026, with the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service on the Issuer's board of directors on the applicable vesting date.
vTv Therapeutics Inc.
Report date February 17, 2026 · Filed February 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $36.92 · Expires 2036-02-17 | Direct | 392,212 |
Reported balance
After 2026-02-17 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-02-17 · Grant · Acquired 140,000 · Balance 392,212 F1: The options vest 25% on the first anniversary of the grant date and in quarterly equal installments thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: The options vest 25% on the first anniversary of the grant date and in quarterly equal installments thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 02, 2020 Filed Jan 7, 2020 01:02 UTC | ALPINE IMMUNE SCIENCES, INC. ALPN · Entity 90802 | GrantStock Option (Right to buy) · Derivative | 7,650 | $0.00 Strike: $3.62 | $0.00 |
DisclosureSEC source: 0000899243-20-000643 · doc4.xml · derivative · entry 1 SEKHRI PAUL J · CIK 0001264519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,650 Underlying: Common Stock · 7,650 shares Expires 2030-01-01 F1 · derivative.exercise_price: The exercise price is equal to the closing price per share of Common Stock as reported on the Nasdaq Global Market on the date of grant. F2 · derivative.exercise_date: 1/12th of the shares subject to the option become vested and exercisable on February 2, 2020 and 1/12th of the shares subject to the option shall vest monthly thereafter. Read SEC document |
| December 20, 2019 Filed Dec 20, 2019 22:44 UTC | VEEVA SYSTEMS INC VEEV · Entity 2124 | Exercise / conversionRestricted Stock Units · Derivative | 300 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-061628 · doc4.xml · derivative · entry 2 SEKHRI PAUL J · CIK 0001264519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 598 Underlying: Class A Common Stock · 300 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer. F1 · date: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act. F3 · derivative.exercise_date: On June 20, 2019, the Reporting Person was granted 1,197 RSUs under the Issuer's 2013 Equity Incentive Plan, of which 1/4 of the RSUs vested on September 20, 2019, with the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service on the Issuer's board of directors on the applicable vesting date. F3 · derivative.expiration_date: On June 20, 2019, the Reporting Person was granted 1,197 RSUs under the Issuer's 2013 Equity Incentive Plan, of which 1/4 of the RSUs vested on September 20, 2019, with the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service on the Issuer's board of directors on the applicable vesting date. Read SEC document |
| December 20, 2019 Filed Dec 20, 2019 22:44 UTC | VEEVA SYSTEMS INC VEEV · Entity 2124 | Exercise / conversionClass A Common Stock | 300 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-061628 · doc4.xml · nonDerivative · entry 1 SEKHRI PAUL J · CIK 0001264519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,850 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act. F2 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer. Read SEC document |
| December 06, 2019 Filed Dec 9, 2019 22:20 UTC | VEEVA SYSTEMS INC VEEV · Entity 2124 | SaleClass A Common Stock | 4,615 | $146.11 | $674,286.57 |
DisclosureSEC source: 0001209191-19-059751 · doc4.xml · nonDerivative · entry 1 SEKHRI PAUL J · CIK 0001264519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,550 Read SEC document |
| October 04, 2019 Filed Oct 8, 2019 20:20 UTC | VEEVA SYSTEMS INC VEEV · Entity 2124 | SaleClass A Common Stock | 628 | $151.00 | $94,828.00 |
DisclosureSEC source: 0001209191-19-052751 · doc4.xml · nonDerivative · entry 1 SEKHRI PAUL J · CIK 0001264519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,165 Read SEC document |
| September 20, 2019 Filed Sep 23, 2019 20:16 UTC | VEEVA SYSTEMS INC VEEV · Entity 2124 | Exercise / conversionRestricted Stock Units · Derivative | 299 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-050453 · doc4.xml · derivative · entry 2 SEKHRI PAUL J · CIK 0001264519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 898 Underlying: Class A Common Stock · 299 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer. F1 · date: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act. F3 · derivative.exercise_date: On June 20, 2019, the Reporting Person was granted 1,197 RSUs under the Issuer's 2013 Equity Incentive Plan, of which 1/4 of the RSUs vested on September 20, 2019, with the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service on the Issuer's board of directors on the applicable vesting date. F3 · derivative.expiration_date: On June 20, 2019, the Reporting Person was granted 1,197 RSUs under the Issuer's 2013 Equity Incentive Plan, of which 1/4 of the RSUs vested on September 20, 2019, with the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service on the Issuer's board of directors on the applicable vesting date. Read SEC document |
| September 20, 2019 Filed Sep 23, 2019 20:16 UTC | VEEVA SYSTEMS INC VEEV · Entity 2124 | Exercise / conversionClass A Common Stock | 299 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-050453 · doc4.xml · nonDerivative · entry 1 SEKHRI PAUL J · CIK 0001264519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,793 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act. F2 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer. Read SEC document |
| June 24, 2019 Filed Jun 25, 2019 20:19 UTC | VEEVA SYSTEMS INC VEEV · Entity 2124 | SaleClass A Common Stock | 601 | $169.38 | $101,797.38 |
DisclosureSEC source: 0001209191-19-038911 · doc4.xml · nonDerivative · entry 1 SEKHRI PAUL J · CIK 0001264519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,494 F1 · kind: The sales reported on this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the Reporting Person. Read SEC document |
| June 20, 2019 Filed Jun 21, 2019 22:25 UTC | VEEVA SYSTEMS INC VEEV · Entity 2124 | GrantRestricted Stock Units · Derivative | 1,197 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-038630 · doc4.xml · derivative · entry 1 SEKHRI PAUL J · CIK 0001264519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,197 Underlying: Class A Common Stock · 1,197 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer. F2 · derivative.exercise_date: The RSUs were granted under the Issuer's 2013 Equity Incentive Plan. The Reporting Person vests ownership in the RSUs over one year, with 1/4 of the RSUs vesting on September 20, 2019, and the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service by the Reporting Person to the Issuer. F2 · derivative.expiration_date: The RSUs were granted under the Issuer's 2013 Equity Incentive Plan. The Reporting Person vests ownership in the RSUs over one year, with 1/4 of the RSUs vesting on September 20, 2019, and the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service by the Reporting Person to the Issuer. Read SEC document |
| June 13, 2019 Filed Jun 17, 2019 20:14 UTC | VEEVA SYSTEMS INC VEEV · Entity 2124 | Exercise / conversionRestricted Stock Units · Derivative | 627 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-037388 · doc4.xml · derivative · entry 2 SEKHRI PAUL J · CIK 0001264519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 627 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer. F1 · date: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act. F3 · derivative.exercise_date: On June 13, 2018, the Reporting Person was granted 2,510 RSUs under the Issuer's 2013 Equity Incentive Plan, of which 1/4 of the RSUs vested on September 13, 2018, with the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service on the Issuer's board of directors on the applicable vesting date. F3 · derivative.expiration_date: On June 13, 2018, the Reporting Person was granted 2,510 RSUs under the Issuer's 2013 Equity Incentive Plan, of which 1/4 of the RSUs vested on September 13, 2018, with the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service on the Issuer's board of directors on the applicable vesting date. Read SEC document |
| June 13, 2019 Filed Jun 17, 2019 20:14 UTC | VEEVA SYSTEMS INC VEEV · Entity 2124 | Exercise / conversionClass A Common Stock | 627 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-037388 · doc4.xml · nonDerivative · entry 1 SEKHRI PAUL J · CIK 0001264519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,095 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act. F2 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer. Read SEC document |
| March 22, 2019 Filed Mar 25, 2019 20:07 UTC | VEEVA SYSTEMS INC VEEV · Entity 2124 | SaleClass A Common Stock | 600 | $127.53 | $76,518.00 |
DisclosureSEC source: 0001209191-19-021148 · doc4.xml · nonDerivative · entry 1 SEKHRI PAUL J · CIK 0001264519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,468 F1 · kind: The sales reported on this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the Reporting Person. Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 20:23 UTC | VEEVA SYSTEMS INC VEEV · Entity 2124 | Exercise / conversionRestricted Stock Units · Derivative | 628 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-019694 · doc4.xml · derivative · entry 2 SEKHRI PAUL J · CIK 0001264519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 627 Underlying: Class A Common Stock · 628 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer. F1 · date: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act. F3 · derivative.exercise_date: On June 13, 2018, the Reporting Person was granted 2,510 RSUs under the Issuer's 2013 Equity Incentive Plan, of which 1/4 of the RSUs vested on September 13, 2018, with the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service on the Issuer's board of directors on the applicable vesting date. F3 · derivative.expiration_date: On June 13, 2018, the Reporting Person was granted 2,510 RSUs under the Issuer's 2013 Equity Incentive Plan, of which 1/4 of the RSUs vested on September 13, 2018, with the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service on the Issuer's board of directors on the applicable vesting date. Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 20:23 UTC | VEEVA SYSTEMS INC VEEV · Entity 2124 | Exercise / conversionClass A Common Stock | 628 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-019694 · doc4.xml · nonDerivative · entry 1 SEKHRI PAUL J · CIK 0001264519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,068 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act. F2 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 21:00 UTC | ALPINE IMMUNE SCIENCES, INC. ALPN · Entity 90802 | GrantStock Option (Right to buy) · Derivative | 7,650 | $0.00 Strike: $4.09 | $0.00 |
DisclosureSEC source: 0000899243-19-000496 · doc4.xml · derivative · entry 1 SEKHRI PAUL J · CIK 0001264519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,650 Underlying: Common Stock · 7,650 shares Expires 2029-01-01 F1 · derivative.exercise_price: The exercise price is equal to the closing price per share of Common Stock as reported on the Nasdaq Global Market on the date of grant. F2 · derivative.exercise_date: 1/12th of the shares subject to the option become vested and exercisable on February 2, 2019 and 1/12th of the shares subject to the option shall vest monthly thereafter. Read SEC document |
| December 26, 2018 Filed Dec 28, 2018 00:54 UTC | VEEVA SYSTEMS INC VEEV · Entity 2124 | SaleClass A Common Stock | 601 | $85.00 | $51,085.00 |
DisclosureSEC source: 0001209191-18-064226 · doc4.xml · nonDerivative · entry 1 SEKHRI PAUL J · CIK 0001264519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,440 F1 · kind: The sales reported on this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the Reporting Person. Read SEC document |
| December 18, 2018 Filed Dec 20, 2018 21:09 UTC | VEEVA SYSTEMS INC VEEV · Entity 2124 | SaleClass A Common Stock | 1,225 | $87.44 | $107,116.70 |
DisclosureSEC source: 0001209191-18-063653 · doc4.xml · nonDerivative · entry 2 SEKHRI PAUL J · CIK 0001264519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,041 F1 · kind: The sales reported on this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the Reporting Person. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.2900 to $87.9900 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 18, 2018 Filed Dec 20, 2018 21:09 UTC | VEEVA SYSTEMS INC VEEV · Entity 2124 | SaleClass A Common Stock | 7,804 | $86.57 | $675,554.04 |
DisclosureSEC source: 0001209191-18-063653 · doc4.xml · nonDerivative · entry 1 SEKHRI PAUL J · CIK 0001264519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,266 F1 · kind: The sales reported on this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the Reporting Person. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.2100 to $87.0600 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 13, 2018 Filed Dec 15, 2018 00:31 UTC | VEEVA SYSTEMS INC VEEV · Entity 2124 | Exercise / conversionRestricted Stock Units · Derivative | 627 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-062827 · doc4.xml · derivative · entry 2 SEKHRI PAUL J · CIK 0001264519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,255 Underlying: Class A Common Stock · 627 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer. F1 · date: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act. F3 · derivative.exercise_date: On June 13, 2018, the Reporting Person was granted 2,510 RSUs under the Issuer's 2013 Equity Incentive Plan, of which 1/4 of the RSUs vested on September 13, 2018, with the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service on the Issuer's board of directors on the applicable vesting date. F3 · derivative.expiration_date: On June 13, 2018, the Reporting Person was granted 2,510 RSUs under the Issuer's 2013 Equity Incentive Plan, of which 1/4 of the RSUs vested on September 13, 2018, with the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service on the Issuer's board of directors on the applicable vesting date. Read SEC document |
| December 13, 2018 Filed Dec 15, 2018 00:31 UTC | VEEVA SYSTEMS INC VEEV · Entity 2124 | Exercise / conversionClass A Common Stock | 627 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-062827 · doc4.xml · nonDerivative · entry 1 SEKHRI PAUL J · CIK 0001264519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,070 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act. F2 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer. Read SEC document |
| December 03, 2018 Filed Dec 4, 2018 22:21 UTC | VEEVA SYSTEMS INC VEEV · Entity 2124 | Exercise / conversionStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $29.46 | $0.00 |
DisclosureSEC source: 0001209191-18-060962 · doc4.xml · derivative · entry 5 SEKHRI PAUL J · CIK 0001264519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 20,000 shares Expires 2024-09-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act. F6 · derivative.exercise_date: The option shares are fully vested and may be exercised at any time. Read SEC document |
| December 03, 2018 Filed Dec 4, 2018 22:21 UTC | VEEVA SYSTEMS INC VEEV · Entity 2124 | SaleClass A Common Stock | 1,300 | $99.09 | $128,811.02 |
DisclosureSEC source: 0001209191-18-060962 · doc4.xml · nonDerivative · entry 4 SEKHRI PAUL J · CIK 0001264519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,443 F2 · kind: The sales reported on this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the Reporting Person. F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.0100 to $99.1500 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 03, 2018 Filed Dec 4, 2018 22:21 UTC | VEEVA SYSTEMS INC VEEV · Entity 2124 | SaleClass A Common Stock | 3,206 | $98.17 | $314,722.44 |
DisclosureSEC source: 0001209191-18-060962 · doc4.xml · nonDerivative · entry 3 SEKHRI PAUL J · CIK 0001264519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,743 F2 · kind: The sales reported on this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the Reporting Person. F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.7700 to $98.6200 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 03, 2018 Filed Dec 4, 2018 22:21 UTC | VEEVA SYSTEMS INC VEEV · Entity 2124 | SaleClass A Common Stock | 1,510 | $97.09 | $146,603.18 |
DisclosureSEC source: 0001209191-18-060962 · doc4.xml · nonDerivative · entry 2 SEKHRI PAUL J · CIK 0001264519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,949 F2 · kind: The sales reported on this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the Reporting Person. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.7600 to $97.7100 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 03, 2018 Filed Dec 4, 2018 22:21 UTC | VEEVA SYSTEMS INC VEEV · Entity 2124 | Exercise / conversionClass A Common Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-060962 · doc4.xml · nonDerivative · entry 1 SEKHRI PAUL J · CIK 0001264519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,459 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act. Read SEC document |
| September 24, 2018 Filed Sep 26, 2018 21:22 UTC | VEEVA SYSTEMS INC VEEV · Entity 2124 | SaleClass A Common Stock | 601 | $103.67 | $62,305.67 |
DisclosureSEC source: 0001209191-18-052324 · doc4.xml · nonDerivative · entry 1 SEKHRI PAUL J · CIK 0001264519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,459 F1 · kind: The sales reported on this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the Reporting Person. Read SEC document |
| September 13, 2018 Filed Sep 14, 2018 20:13 UTC | VEEVA SYSTEMS INC VEEV · Entity 2124 | Exercise / conversionRestricted Stock Units · Derivative | 628 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-051071 · doc4.xml · derivative · entry 2 SEKHRI PAUL J · CIK 0001264519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,882 Underlying: Class A Common Stock · 628 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer. F1 · date: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act. F3 · derivative.exercise_date: On June 13, 2018, the Reporting Person was granted 2,510 RSUs under the Issuer's 2013 Equity Incentive Plan, of which 1/4 of the RSUs vested on September 13, 2018, with the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service on the Issuer's board of directors on the applicable vesting date. F3 · derivative.expiration_date: On June 13, 2018, the Reporting Person was granted 2,510 RSUs under the Issuer's 2013 Equity Incentive Plan, of which 1/4 of the RSUs vested on September 13, 2018, with the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service on the Issuer's board of directors on the applicable vesting date. Read SEC document |
| September 13, 2018 Filed Sep 14, 2018 20:13 UTC | VEEVA SYSTEMS INC VEEV · Entity 2124 | Exercise / conversionClass A Common Stock | 628 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-051071 · doc4.xml · nonDerivative · entry 1 SEKHRI PAUL J · CIK 0001264519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,060 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act. F2 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer. Read SEC document |
| June 25, 2018 Filed Jun 27, 2018 20:31 UTC | VEEVA SYSTEMS INC VEEV · Entity 2124 | SaleClass A Common Stock | 1,107 | $82.80 | $91,659.60 |
DisclosureSEC source: 0001209191-18-039662 · doc4.xml · nonDerivative · entry 1 SEKHRI PAUL J · CIK 0001264519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,432 F1 · kind: The sales reported on this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the Reporting Person. Read SEC document |
| June 21, 2018 Filed Jun 22, 2018 21:56 UTC | VEEVA SYSTEMS INC VEEV · Entity 2124 | Exercise / conversionRestricted Stock Units · Derivative | 601 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-039300 · doc4.xml · derivative · entry 2 SEKHRI PAUL J · CIK 0001264519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 601 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer. F1 · date: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act. F3 · derivative.exercise_date: On June 21, 2017, the Reporting Person was granted 2,403 RSUs under the Issuer's 2013 Equity Incentive Plan, of which 1/4 of the RSUs vested on September 21, 2017, with the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service on the Issuer's board of directors on the applicable vesting date. F3 · derivative.expiration_date: On June 21, 2017, the Reporting Person was granted 2,403 RSUs under the Issuer's 2013 Equity Incentive Plan, of which 1/4 of the RSUs vested on September 21, 2017, with the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service on the Issuer's board of directors on the applicable vesting date. Read SEC document |
| June 21, 2018 Filed Jun 22, 2018 21:56 UTC | VEEVA SYSTEMS INC VEEV · Entity 2124 | Exercise / conversionClass A Common Stock | 601 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-039300 · doc4.xml · nonDerivative · entry 1 SEKHRI PAUL J · CIK 0001264519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,539 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act. F2 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer. Read SEC document |
| June 13, 2018 Filed Jun 15, 2018 21:15 UTC | VEEVA SYSTEMS INC VEEV · Entity 2124 | GrantRestricted Stock Units · Derivative | 2,510 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-038120 · doc4.xml · derivative · entry 1 SEKHRI PAUL J · CIK 0001264519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,510 Underlying: Class A Common Stock · 2,510 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer. F2 · derivative.exercise_date: The RSUs were granted under the Issuer's 2013 Equity Incentive Plan. The Reporting Person vests ownership in the RSUs over one year, with 1/4 of the RSUs vesting on September 13, 2018, and the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service by the Reporting Person to the Issuer. F2 · derivative.expiration_date: The RSUs were granted under the Issuer's 2013 Equity Incentive Plan. The Reporting Person vests ownership in the RSUs over one year, with 1/4 of the RSUs vesting on September 13, 2018, and the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service by the Reporting Person to the Issuer. Read SEC document |
| March 23, 2018 Filed Mar 23, 2018 20:57 UTC | VEEVA SYSTEMS INC VEEV · Entity 2124 | SaleClass A Common Stock | 1,108 | $75.46 | $83,609.68 |
DisclosureSEC source: 0001209191-18-021423 · doc4.xml · nonDerivative · entry 2 SEKHRI PAUL J · CIK 0001264519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,938 F3 · kind: The sales reported on this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the Reporting Person. Read SEC document |
| March 21, 2018 Filed Mar 23, 2018 20:57 UTC | VEEVA SYSTEMS INC VEEV · Entity 2124 | Exercise / conversionRestricted Stock Units · Derivative | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-021423 · doc4.xml · derivative · entry 3 SEKHRI PAUL J · CIK 0001264519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 601 Underlying: Class A Common Stock · 600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer. F1 · date: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act. F4 · derivative.exercise_date: On June 21, 2017, the Reporting Person was granted 2,403 RSUs under the Issuer's 2013 Equity Incentive Plan, of which 1/4 of the RSUs vested on September 21, 2017, with the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service on the Issuer's board of directors on the applicable vesting date. F4 · derivative.expiration_date: On June 21, 2017, the Reporting Person was granted 2,403 RSUs under the Issuer's 2013 Equity Incentive Plan, of which 1/4 of the RSUs vested on September 21, 2017, with the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service on the Issuer's board of directors on the applicable vesting date. Read SEC document |
| March 21, 2018 Filed Mar 23, 2018 20:57 UTC | VEEVA SYSTEMS INC VEEV · Entity 2124 | Exercise / conversionClass A Common Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-021423 · doc4.xml · nonDerivative · entry 1 SEKHRI PAUL J · CIK 0001264519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,046 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act. F2 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer. Read SEC document |
| February 28, 2018 Filed Mar 1, 2018 21:24 UTC | VEEVA SYSTEMS INC VEEV · Entity 2124 | SaleClass A Common Stock | 4,622 | $65.00 | $300,430.00 |
DisclosureSEC source: 0001209191-18-015025 · doc4.xml · nonDerivative · entry 1 SEKHRI PAUL J · CIK 0001264519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,446 F1 · kind: The sales reported on this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the Reporting Person. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 22:34 UTC | ALPINE IMMUNE SCIENCES, INC. ALPN · Entity 90802 | GrantStock Option (Right to buy) · Derivative | 7,650 | $0.00 Strike: $11.31 | $0.00 |
DisclosureSEC source: 0000899243-18-000501 · doc4.xml · derivative · entry 1 SEKHRI PAUL J · CIK 0001264519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,650 Underlying: Common Stock · 7,650 shares Expires 2028-01-01 F1 · derivative.exercise_price: The exercise price is equal to the closing price per share of Common Stock as reported on the Nasdaq Global Market on the date of grant. F2 · derivative.exercise_date: 100% of the shares subject to the option become vested and exercisable on January 2, 2019. Read SEC document |
| December 21, 2017 Filed Dec 22, 2017 22:17 UTC | VEEVA SYSTEMS INC VEEV · Entity 2124 | Exercise / conversionRestricted Stock Units · Derivative | 601 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-067120 · doc4.xml · derivative · entry 2 SEKHRI PAUL J · CIK 0001264519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,201 Underlying: Class A Common Stock · 601 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer. F1 · date: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act. F3 · derivative.exercise_date: On June 21, 2017, the Reporting Person was granted 2,403 RSUs under the Issuer's 2013 Equity Incentive Plan, of which 1/4 of the RSUs vested on September 21, 2017, with the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service on the Issuer's board of directors on the applicable vesting date. F3 · derivative.expiration_date: On June 21, 2017, the Reporting Person was granted 2,403 RSUs under the Issuer's 2013 Equity Incentive Plan, of which 1/4 of the RSUs vested on September 21, 2017, with the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service on the Issuer's board of directors on the applicable vesting date. Read SEC document |
| December 21, 2017 Filed Dec 22, 2017 22:17 UTC | VEEVA SYSTEMS INC VEEV · Entity 2124 | Exercise / conversionClass A Common Stock | 601 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-067120 · doc4.xml · nonDerivative · entry 1 SEKHRI PAUL J · CIK 0001264519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,068 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act. F2 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer. Read SEC document |
| December 07, 2017 Filed Dec 8, 2017 23:44 UTC | VEEVA SYSTEMS INC VEEV · Entity 2124 | Exercise / conversionStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $29.46 | $0.00 |
DisclosureSEC source: 0001209191-17-064850 · doc4.xml · derivative · entry 3 SEKHRI PAUL J · CIK 0001264519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Class A Common Stock · 20,000 shares Expires 2024-09-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act. F4 · derivative.exercise_date: The option shares are fully vested and may be exercised at any time. Read SEC document |
| December 07, 2017 Filed Dec 8, 2017 23:44 UTC | VEEVA SYSTEMS INC VEEV · Entity 2124 | SaleClass A Common Stock | 10,971 | $53.83 | $590,544.79 |
DisclosureSEC source: 0001209191-17-064850 · doc4.xml · nonDerivative · entry 2 SEKHRI PAUL J · CIK 0001264519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,467 F2 · kind: The sales reported on this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the Reporting Person. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.7600 to $54.3250 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 07, 2017 Filed Dec 8, 2017 23:44 UTC | VEEVA SYSTEMS INC VEEV · Entity 2124 | Exercise / conversionClass A Common Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-064850 · doc4.xml · nonDerivative · entry 1 SEKHRI PAUL J · CIK 0001264519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,438 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act. Read SEC document |
| September 21, 2017 Filed Sep 25, 2017 20:58 UTC | VEEVA SYSTEMS INC VEEV · Entity 2124 | Exercise / conversionRestricted Stock Units · Derivative | 601 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-053840 · doc4.xml · derivative · entry 2 SEKHRI PAUL J · CIK 0001264519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,802 Underlying: Class A Common Stock · 601 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer. F1 · date: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act. F3 · derivative.exercise_date: On June 21, 2017, the Reporting Person was granted 2,403 RSUs under the Issuer's 2013 Equity Incentive Plan, of which 1/4 of the RSUs will vest on September 21, 2017, with the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service on the Issuer's board of directors on the applicable vesting date. F3 · derivative.expiration_date: On June 21, 2017, the Reporting Person was granted 2,403 RSUs under the Issuer's 2013 Equity Incentive Plan, of which 1/4 of the RSUs will vest on September 21, 2017, with the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service on the Issuer's board of directors on the applicable vesting date. Read SEC document |
| September 21, 2017 Filed Sep 25, 2017 20:58 UTC | VEEVA SYSTEMS INC VEEV · Entity 2124 | Exercise / conversionClass A Common Stock | 601 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-053840 · doc4.xml · nonDerivative · entry 1 SEKHRI PAUL J · CIK 0001264519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,438 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act. F2 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer. Read SEC document |
| June 22, 2017 Filed Jun 23, 2017 20:28 UTC | VEEVA SYSTEMS INC VEEV · Entity 2124 | Exercise / conversionRestricted Stock Units · Derivative | 1,107 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-041651 · doc4.xml · derivative · entry 3 SEKHRI PAUL J · CIK 0001264519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 1,107 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer. F1 · date: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act. F4 · derivative.exercise_date: On June 22, 2016, the Reporting Person was granted 4,430 RSUs under the Issuer's 2013 Equity Incentive Plan, of which 1/4 of the RSUs will vest on September 22, 2016, and the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service on the Issuer's board of directors on the applicable vesting date. F4 · derivative.expiration_date: On June 22, 2016, the Reporting Person was granted 4,430 RSUs under the Issuer's 2013 Equity Incentive Plan, of which 1/4 of the RSUs will vest on September 22, 2016, and the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service on the Issuer's board of directors on the applicable vesting date. Read SEC document |
| June 22, 2017 Filed Jun 23, 2017 20:28 UTC | VEEVA SYSTEMS INC VEEV · Entity 2124 | Exercise / conversionClass A Common Stock | 1,107 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-041651 · doc4.xml · nonDerivative · entry 1 SEKHRI PAUL J · CIK 0001264519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,837 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act. F2 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer. Read SEC document |
| June 21, 2017 Filed Jun 23, 2017 20:28 UTC | VEEVA SYSTEMS INC VEEV · Entity 2124 | GrantRestricted Stock Units · Derivative | 2,403 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-041651 · doc4.xml · derivative · entry 2 SEKHRI PAUL J · CIK 0001264519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,403 Underlying: Class A Common Stock · 2,403 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer. F3 · derivative.exercise_date: The RSUs were granted under the Issuer's 2013 Equity Incentive Plan. The Reporting Person vests ownership in the RSUs over one year, with 1/4 of the RSUs vesting on September 21, 2017, and the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service by the Reporting Person to the Issuer. F3 · derivative.expiration_date: The RSUs were granted under the Issuer's 2013 Equity Incentive Plan. The Reporting Person vests ownership in the RSUs over one year, with 1/4 of the RSUs vesting on September 21, 2017, and the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service by the Reporting Person to the Issuer. Read SEC document |
| March 22, 2017 Filed Mar 24, 2017 20:49 UTC | VEEVA SYSTEMS INC VEEV · Entity 2124 | Exercise / conversionRestricted Stock Units · Derivative | 1,108 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-022775 · doc4.xml · derivative · entry 2 SEKHRI PAUL J · CIK 0001264519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,107 Underlying: Class A Common Stock · 1,108 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer. F1 · date: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act. F3 · derivative.exercise_date: On June 22, 2016, the Reporting Person was granted 4,430 RSUs under the Issuer's 2013 Equity Incentive Plan, of which 1/4 of the RSUs will vest on September 22, 2016, and the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service on the Issuer's board of directors on the applicable vesting date. F3 · derivative.expiration_date: On June 22, 2016, the Reporting Person was granted 4,430 RSUs under the Issuer's 2013 Equity Incentive Plan, of which 1/4 of the RSUs will vest on September 22, 2016, and the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service on the Issuer's board of directors on the applicable vesting date. Read SEC document |
| March 22, 2017 Filed Mar 24, 2017 20:49 UTC | VEEVA SYSTEMS INC VEEV · Entity 2124 | Exercise / conversionClass A Common Stock | 1,108 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-022775 · doc4.xml · nonDerivative · entry 1 SEKHRI PAUL J · CIK 0001264519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,730 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act. F2 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer. Read SEC document |
| December 22, 2016 Filed Dec 28, 2016 00:04 UTC | VEEVA SYSTEMS INC VEEV · Entity 2124 | Exercise / conversionRestricted Stock Units · Derivative | 1,107 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-156847 · doc4.xml · derivative · entry 2 SEKHRI PAUL J · CIK 0001264519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,215 Underlying: Class A Common Stock · 1,107 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer. F1 · date: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act. F3 · derivative.exercise_date: On June 22, 2016, the Reporting Person was granted 4,430 RSUs under the Issuer's 2013 Equity Incentive Plan, of which 1/4 of the RSUs will vest on September 22, 2016, and the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service on the Issuer's board of directors on the applicable vesting date. F3 · derivative.expiration_date: On June 22, 2016, the Reporting Person was granted 4,430 RSUs under the Issuer's 2013 Equity Incentive Plan, of which 1/4 of the RSUs will vest on September 22, 2016, and the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service on the Issuer's board of directors on the applicable vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.